Literature DB >> 16553017

Brief airway occlusion produces prolonged reflex inhibition of inspiratory muscles in obstructive sleep apnea.

Sandra Jeffery1, Jane E Butler, David K McKenzie, Lexin Wang, Simon C Gandevia.   

Abstract

STUDY
OBJECTIVES: The human inspiratory muscles respond to a brief occlusion of the upper airway during inspiration with a profound short-latency reflex inhibition. This inhibition contrasts with the excitatory stretch reflex of limb muscles and may protect the airway from aspiration. It was postulated that this reflex would be altered in subjects with obstructive sleep apnea (OSA) who have repetitive upper airway occlusion.
DESIGN: Subjects underwent overnight polysomnography, as well as muscle reflex studies. For the reflex studies (performed during wakefulness), occlusions lasting 250 milliseconds were delivered during inspiration. Surface electromyogram was recorded over the scalenes, parasternal intercostals, and chest wall (overlying diaphragm).
SETTING: Research and sleep laboratories. PARTICIPANTS: Nineteen subjects with untreated OSA (9 moderate and 10 severe) and 9 healthy control subjects. MEASUREMENTS AND
RESULTS: In the subjects with severe OSA, the duration of the inhibition was prolonged by at least 25% compared with control subjects. The peak of the inhibitory response for scalenes occurred significantly later for subjects with severe OSA than for control subjects (by 76 +/- 5 ms vs 60 +/- 3 ms [mean +/- SEM], respectively). Onset latencies of the later excitatory response were delayed for scalenes, parasternal intercostals, and chest wall recordings (eg, scalenes: 105 +/- 9 ms for subjects with severe OSA vs 83 +/- 5 ms for control subjects).
CONCLUSIONS: The latency of peak inhibition and duration of inhibition were positively correlated with the respiratory disturbance index for all muscle groups. These changes may reflect adaptation in central respiratory paths due to repetitive loading during sleep.

Entities:  

Mesh:

Year:  2006        PMID: 16553017     DOI: 10.1093/sleep/29.3.321

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  6 in total

1.  A secondary reflex suppression phase is present in genioglossus but not tensor palatini in response to negative upper airway pressure.

Authors:  Danny J Eckert; Julian P Saboisky; Amy S Jordan; David P White; Atul Malhotra
Journal:  J Appl Physiol (1985)       Date:  2010-04-08

2.  Genioglossus reflex inhibition to upper-airway negative-pressure stimuli during wakefulness and sleep in healthy males.

Authors:  Danny J Eckert; R Doug McEvoy; Kate E George; Kieron J Thomson; Peter G Catcheside
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

3.  Comment on the article "Prevalence of probable obstructive sleep apnea risk and severity in a population of dental patients" by D.J. Levendowski et al.

Authors:  Mak A Daulatzai; Ahsan H Khandoker; Neela Khan
Journal:  Sleep Breath       Date:  2009-03-04       Impact factor: 2.816

4.  Genioglossus reflex responses to negative upper airway pressure are altered in people with tetraplegia and obstructive sleep apnoea.

Authors:  Nirupama S Wijesuriya; Laura Gainche; Amy S Jordan; David J Berlowitz; Mariannick LeGuen; Peter D Rochford; Fergal J O'Donoghue; Warren R Ruehland; Jayne C Carberry; Jane E Butler; Danny J Eckert
Journal:  J Physiol       Date:  2018-04-25       Impact factor: 5.182

5.  Coordination of respiratory muscles assessed by means of nonlinear forecasting of demodulated myographic signals.

Authors:  Joan F Alonso; Miguel A Mañanas; Mónica Rojas; Eugene N Bruce
Journal:  J Electromyogr Kinesiol       Date:  2011-08-06       Impact factor: 2.368

6.  Continuous Positive Airway Pressure and Breathlessness in Obese Patients with Obstructive Sleep Apnea: A Pilot Study.

Authors:  Sichang Xiao; Johan Bastianpillai; Culadeeban Ratneswaran; Martino F Pengo; Yuanming Luo; Caroline J Jolley; John Moxham; Joerg Steier
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.